Myriad Genetics Inc (MYGN) — Cash Flow-to-Debt Ratio
Myriad Genetics Inc (MYGN) has a Cash Flow-to-Debt Ratio of -0.05x as of March 2026, meaning its operating cash flow of $-15.70 Million could theoretically repay 0% of its total liabilities ($336.30 Million) in one year. Explore MYGN long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Myriad Genetics Inc Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Myriad Genetics Inc across 30 annual periods. Also explore total assets of Myriad Genetics Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Myriad Genetics Inc (1995–2025)
Year-by-year debt coverage analysis for Myriad Genetics Inc. For market capitalisation and broader financial context, see Myriad Genetics Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $1.80 Million | $338.60 Million | ▲ +120.0% |
| 2024 | -0.03x | $-8.70 Million | $326.50 Million | ▲ +91.3% |
| 2023 | -0.31x | $-110.90 Million | $363.30 Million | ▲ +10.1% |
| 2022 | -0.34x | $-106.30 Million | $312.90 Million | ▼ -744.6% |
| 2021 | 0.05x | $18.60 Million | $352.90 Million | ▼ -66.1% |
| 2020 | 0.16x | $83.70 Million | $537.80 Million | ▼ -11.9% |
| 2019 | 0.18x | $83.70 Million | $473.80 Million | ▼ -68.1% |
| 2018 | 0.55x | $115.90 Million | $209.20 Million | ▲ +133.0% |
| 2017 | 0.24x | $106.20 Million | $446.60 Million | ▼ -81.1% |
| 2016 | 1.26x | $166.30 Million | $132.40 Million | ▼ -6.9% |
| 2015 | 1.35x | $140.50 Million | $104.10 Million | ▼ -25.6% |
| 2014 | 1.81x | $190.20 Million | $104.82 Million | ▼ -21.5% |
| 2013 | 2.31x | $173.90 Million | $75.23 Million | ▼ -10.4% |
| 2012 | 2.58x | $141.80 Million | $54.98 Million | ▼ -13.2% |
| 2011 | 2.97x | $130.83 Million | $44.03 Million | ▼ -30.5% |
| 2010 | 4.28x | $155.09 Million | $36.27 Million | ▲ +63.9% |
| 2009 | 2.61x | $84.04 Million | $32.20 Million | ▲ +85.4% |
| 2008 | 1.41x | $103.74 Million | $73.69 Million | ▲ +272.7% |
| 2007 | -0.82x | $-25.85 Million | $31.70 Million | ▲ +22.0% |
| 2006 | -1.04x | $-28.03 Million | $26.82 Million | ▼ -4.4% |
| 2005 | -1.00x | $-23.30 Million | $23.29 Million | ▲ +51.1% |
| 2004 | -2.05x | $-30.88 Million | $15.08 Million | ▲ +14.9% |
| 2003 | -2.41x | $-46.54 Million | $19.34 Million | ▼ -320.8% |
| 2002 | -0.57x | $-16.31 Million | $28.52 Million | ▼ -393.6% |
| 2001 | -0.12x | $-3.78 Million | $32.58 Million | ▼ -119.4% |
| 2000 | 0.60x | $17.16 Million | $28.67 Million | ▲ +122.9% |
| 1999 | -2.61x | $-14.10 Million | $5.40 Million | ▼ -269.3% |
| 1998 | -0.71x | $-7.00 Million | $9.90 Million | ▼ -6.1% |
| 1997 | -0.67x | $-6.60 Million | $9.90 Million | ▼ -547.6% |
| 1995 | 0.15x | $1.40 Million | $9.40 Million | — |